Hepatic metabolism of imipramine after prolonged administration of the drug to rats. An in vivo study

Pol J Pharmacol Pharm. 1987 Jul-Aug;39(4):379-86.

Abstract

The effect of prolonged administration of imipramine (IMI) to rats on the biliary excretion of IMI and its metabolites desipramine (DMI), 2-OH-imipramine (2-OH-IMI) and 2-OH-desipramine (2-OH-DMI) has been investigated. It was found that chronic IMI decreased the ratio DMI/IMI and 2-OH-IMI/IMI excreted with the bile and increased the ratio 2-OH-DMI/DMI. This was observed for 3 h after the last dose of chronic IMI, and suggested an inhibition of IMI demethylation and hydroxylation, and acceleration of DMI hydroxylation. 6 h after the dose of IMI the biliary ratio DMI/IMI and 2-OH-IMI/IMI increased and this might indicate an acceleration of IMI metabolism at later time intervals after IMI administration.

MeSH terms

  • Animals
  • Bile / drug effects
  • Bile / metabolism
  • Biotransformation
  • Desipramine / metabolism
  • Imipramine / analogs & derivatives
  • Imipramine / metabolism
  • Imipramine / pharmacokinetics*
  • Liver / metabolism*
  • Male
  • Rats
  • Rats, Inbred Strains

Substances

  • 2-hydroxyimipramine
  • Imipramine
  • Desipramine